GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹37 Cr | ₹36 Cr | ₹36 Cr | ₹32 Cr | ₹26 Cr |
What is the latest Total Current Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹36 Cr |
| Mar2023 | ₹36 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹26 Cr |
How is Total Current Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | 2.93 | |
| Mar2024 | ₹36 Cr | 1.39 | |
| Mar2023 | ₹36 Cr | 12.71 | |
| Mar2022 | ₹32 Cr | 22.45 | |
| Mar2021 | ₹26 Cr | - | |
Compare Total Current Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,082.0 Cr | 15.1% | -6.1% | -3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -0.9% | -3.9% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -0.4% | -7.6% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -2% | -7.5% | 27.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -1.5% | -9.3% | 3.8% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | 1.7% | -8.3% | -16.8% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 15.1% |
-6.1% |
-3% |
| SENSEX | 7.8% |
-2% |
0.2% |
You may also like the below Video Courses